← Leaderboards
Nikolaus Jilg
Massachusetts General Hospital
$798,480
Attributed
$798,480
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $199.8K · FY2021–24$200K$150K$100K$50K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$798,480 · 1
By mechanism
K08$798,480 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Mathias Lichterfeld$34,368,889
- Richard T D'aquila$62,924,506
- Athe M. Tsibris$17,945,517
- Todd M Allen$28,600,717
- Ahmed A Tawakol$9,912,063
Others in their field
Other Emerging Leaders on “Advisory Committees”
- Claudia Valmonte · The Emmes Company, Llc$37,865,589
- James Lu · Helix$12,461,593
- Hemali Phatnani · New York University School Of Medicine$12,067,974
- Patrick A Flume · Medical University Of South Carolina$11,656,627
- Sonia Savelli · University Of Washington$11,147,222
- Rajni Samavedam · Booz Allen Hamilton$9,935,296
Research focus
Advisory CommitteesAfrica South Of The SaharaAffectAntibodiesAntibody TherapyAntiretroviral TherapyAids Clinical Trial GroupBasic ScienceBindingBotswanaCareer DevelopmentChildChronicClinical DataClinical TrialsCollectionCombined Modality TherapyCommunicable DiseasesDeep SequencingDesignDevelopment PlansDideoxy Chain Termination Dna SequencingDisease RemissionDrug Resistance
Grant awards (4)
Relevance of Resistance Mutations for the Susceptibility to Broadly Neutralizing Antibodies Against HIV-1$199,800
K08 · FY2024 · AI · contact PI
Relevance of Resistance Mutations for the Susceptibility to Broadly Neutralizing Antibodies Against HIV-1$199,800
K08 · FY2023 · AI · contact PI
Relevance of Resistance Mutations for the Susceptibility to Broadly Neutralizing Antibodies Against HIV-1$199,320
K08 · FY2022 · AI · contact PI
Relevance of Resistance Mutations for the Susceptibility to Broadly Neutralizing Antibodies Against HIV-1$199,560
K08 · FY2021 · AI · contact PI